CETIRIZINE HYDROCHLORIDE

CETIRIZINE HYDROCHLORIDE was reported 167970 times

CETIRIZINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5527 0.7706
1 SWOLLEN JOINT COUNT INCREASED 2335 0.7315
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 484 0.7246
3 CARDIOSPASM 402 0.7204
4 RHEUMATIC FEVER 3173 0.7111
5 PEMPHIGUS 8677 0.6933
6 DUODENAL ULCER PERFORATION 5115 0.6871
7 DEEP VEIN THROMBOSIS POSTOPERATIVE 1338 0.6680
8 LUPUS VULGARIS 822 0.6524
9 C-REACTIVE PROTEIN 576 0.6214
10 RHEUMATOID FACTOR POSITIVE 3472 0.6005
11 IMMUNISATION 259 0.5968
12 GRIP STRENGTH 135 0.5895
13 FACET JOINT SYNDROME 1911 0.5864
14 VAGINAL FLATULENCE 172 0.5677
15 SWOLLEN JOINT COUNT 139 0.5560
16 HAND DEFORMITY 7177 0.5467
17 PALMOPLANTAR KERATODERMA 389 0.5366
18 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1093 0.5270
19 HELICOBACTER INFECTION 5082 0.4940
20 MUSCLE INJURY 3947 0.4759
21 DISLOCATION OF VERTEBRA 1073 0.4700
22 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2819 0.4336
23 FOLLICULITIS 4469 0.4257
24 X-RAY ABNORMAL 758 0.4235
25 RETINITIS 702 0.4060
26 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 224 0.3993
27 PERICARDITIS 6580 0.3912
28 GLOSSODYNIA 8273 0.3691
29 PERIPHERAL VENOUS DISEASE 1431 0.3500
30 SYNOVITIS 6284 0.3482
31 SERONEGATIVE ARTHRITIS 349 0.3045
32 HYPOCHOLESTEROLAEMIA 104 0.2946
33 C-REACTIVE PROTEIN ABNORMAL 1707 0.2658
34 SYSTEMIC LUPUS ERYTHEMATOSUS 9013 0.2537
35 WOUND 7040 0.2516
36 BREAST CANCER STAGE III 1573 0.2426
37 CONTRAINDICATED PRODUCT ADMINISTERED 6796 0.2242
38 TEMPERATURE REGULATION DISORDER 482 0.2161
39 LIP DRY 1943 0.2137
40 IRRITABLE BOWEL SYNDROME 4543 0.2117
41 BONE EROSION 728 0.2056
42 PORPHYRIA ACUTE 286 0.1993
43 ATRIAL TACHYCARDIA 414 0.1970
44 CHRONIC SPONTANEOUS URTICARIA 227 0.1957
45 BURSITIS 2320 0.1910
46 PRURITUS GENITAL 447 0.1896
47 ONYCHOMADESIS 778 0.1852
48 GRIP STRENGTH DECREASED 1601 0.1817
49 HYPERCHOLESTEROLAEMIA 1746 0.1807
50 LIVE BIRTH 1489 0.1778
51 OVERLAP SYNDROME 124 0.1771
52 JOINT RANGE OF MOTION DECREASED 2341 0.1744
53 DRUG TOLERANCE DECREASED 485 0.1725
54 BLEPHAROSPASM 1072 0.1701
55 WOUND INFECTION 1853 0.1690
56 AUTOIMMUNE DISORDER 1445 0.1481
57 FIBROMYALGIA 3565 0.1465
58 JOINT DESTRUCTION 223 0.1433
59 ONYCHOMYCOSIS 629 0.1432
60 IMPAIRED HEALING 4596 0.1398
61 ELECTRIC SHOCK 118 0.1377
62 ARTHROPATHY 7330 0.1317
63 LIVER INJURY 3181 0.1295
64 SLEEP TERROR 540 0.1281
65 CHRONIC SINUSITIS 457 0.1216
66 TYPE 2 DIABETES MELLITUS 4028 0.1195
67 INFUSION RELATED REACTION 7850 0.1183
68 MAST CELL ACTIVATION SYNDROME 165 0.1175
69 DEATH NEONATAL 163 0.1171
70 INFUSION SITE REACTION 349 0.1167
71 OBESITY 1847 0.1158
72 COELIAC DISEASE 1111 0.1131
73 FOOD ALLERGY 868 0.1123
74 CAROTID ARTERY OCCLUSION 410 0.1123
75 NAIL DISORDER 961 0.1097
76 MATERNAL EXPOSURE TIMING UNSPECIFIED 412 0.1096
77 FEMALE GENITAL TRACT FISTULA 187 0.1094
78 WRONG PATIENT RECEIVED MEDICATION 291 0.1065
79 FINGER DEFORMITY 516 0.1064
80 PRESCRIBED OVERDOSE 2060 0.1064
81 DISCOMFORT 6446 0.1055
82 TENSION HEADACHE 454 0.1055
83 LOWER RESPIRATORY TRACT INFECTION 4764 0.1046
84 THERAPEUTIC PRODUCT EFFECT DECREASED 4597 0.1025
85 HEPATIC ENZYME INCREASED 6822 0.1000
86 SCIATICA 1570 0.0984
87 PSORIATIC ARTHROPATHY 3985 0.0981
88 EXOSTOSIS 893 0.0977
89 BLISTER 5399 0.0960
90 SWELLING 8942 0.0954
91 HIP ARTHROPLASTY 1449 0.0945
92 RED BLOOD CELL SEDIMENTATION RATE INCREASED 965 0.0871
93 WALKING AID USER 571 0.0865
94 RHEUMATOID ARTHRITIS 9522 0.0838
95 BLOOD IMMUNOGLOBULIN E INCREASED 201 0.0829
96 RADICULOPATHY 218 0.0826
97 LUPUS-LIKE SYNDROME 738 0.0813
98 BLOOD CHOLESTEROL INCREASED 3730 0.0799
99 PULMONARY FIBROSIS 1527 0.0795
100 STOMATITIS 4788 0.0789
101 INFUSION SITE DISCHARGE 137 0.0781
102 LOWER LIMB FRACTURE 1458 0.0758
103 PRODUCT LABEL CONFUSION 434 0.0744
104 BACK INJURY 806 0.0740
105 MACULAR DEGENERATION 869 0.0727
106 MATERNAL EXPOSURE DURING PREGNANCY 6485 0.0727
107 PROCTITIS 203 0.0724
108 KNEE ARTHROPLASTY 1524 0.0723
109 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 439 0.0721
110 WHEEZING 4246 0.0715
111 NIGHT SWEATS 2292 0.0711
112 DRUG INTOLERANCE 6777 0.0701
113 PUSTULAR PSORIASIS 239 0.0695
114 JOINT DISLOCATION 733 0.0693
115 FOOT DEFORMITY 764 0.0689
116 INTERVERTEBRAL DISCITIS 127 0.0673
117 DRUG TOLERANCE 337 0.0665
118 FORCED EXPIRATORY VOLUME DECREASED 188 0.0663
119 JOINT SWELLING 7963 0.0659
120 GAIT INABILITY 2200 0.0658
121 CONGENITAL ANOMALY 509 0.0657
122 FACIAL PAIN 583 0.0652
123 ABDOMINAL DISCOMFORT 10897 0.0649
124 BREAST CANCER STAGE II 534 0.0641
125 SINUSITIS 6578 0.0641
126 SPONDYLITIS 232 0.0637
127 OSTEOARTHRITIS 2667 0.0628
128 INFUSION SITE PRURITUS 196 0.0621
129 SEASONAL ALLERGY 878 0.0620
130 EYE INJURY 188 0.0618
131 ILL-DEFINED DISORDER 3728 0.0613
132 IMMUNODEFICIENCY 898 0.0602
133 ORAL PRURITUS 138 0.0601
134 RASH VESICULAR 290 0.0599
135 ULCER HAEMORRHAGE 402 0.0593
136 FOETAL DEATH 305 0.0588
137 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 134 0.0581
138 INFUSION SITE BRUISING 124 0.0574
139 RHINITIS ALLERGIC 255 0.0572
140 PRESCRIBED UNDERDOSE 1137 0.0569
141 WHITE BLOOD CELLS URINE POSITIVE 107 0.0568
142 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 403 0.0562
143 EAR PAIN 1089 0.0560
144 TASTE DISORDER 1130 0.0556
145 ALOPECIA 10742 0.0546
146 HYPERSENSITIVITY 10141 0.0546
147 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 292 0.0536
148 INFUSION SITE HAEMORRHAGE 176 0.0534
149 SLEEP DISORDER 3757 0.0532
150 INJURY 3736 0.0531
151 TREATMENT FAILURE 4355 0.0525
152 MOBILITY DECREASED 3721 0.0517
153 PULMONARY PAIN 151 0.0517
154 URTICARIA 8641 0.0515
155 EAR INFECTION 1357 0.0509
156 SUBARACHNOID HAEMORRHAGE 505 0.0495
157 SPINAL FUSION SURGERY 201 0.0495
158 INFLAMMATION 2553 0.0494
159 MULTIPLE ALLERGIES 385 0.0491
160 HYPERPARATHYROIDISM SECONDARY 123 0.0490
161 THERAPEUTIC RESPONSE UNEXPECTED 2199 0.0490
162 C-REACTIVE PROTEIN INCREASED 1780 0.0489
163 EXPOSURE DURING PREGNANCY 3036 0.0488
164 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 824 0.0485
165 GASTROINTESTINAL DISORDER 4326 0.0482
166 OEDEMA 2552 0.0470
167 MUSCULOSKELETAL STIFFNESS 4108 0.0468
168 INTENTIONAL PRODUCT USE ISSUE 4071 0.0464
169 INFUSION SITE SWELLING 290 0.0460
170 ASTHMA 5176 0.0457
171 NORMAL NEWBORN 248 0.0456
172 LIVER FUNCTION TEST INCREASED 977 0.0455
173 HEPATIC CIRRHOSIS 841 0.0447
174 ROAD TRAFFIC ACCIDENT 1866 0.0446
175 EPILEPSY 1361 0.0445
176 CONTUSION 4242 0.0440
177 PRE-EXISTING CONDITION IMPROVED 274 0.0438
178 LUNG DISORDER 2139 0.0436
179 NEPHROGENIC ANAEMIA 199 0.0429
180 UPPER RESPIRATORY TRACT INFECTION 1983 0.0429
181 DRY MOUTH 3473 0.0428
182 GENERAL PHYSICAL HEALTH DETERIORATION 4936 0.0426
183 POLYARTHRITIS 224 0.0424
184 VASCULITIS 490 0.0420
185 ANOSMIA 602 0.0415
186 PERIPHERAL SWELLING 6349 0.0412
187 OBSTRUCTIVE AIRWAYS DISORDER 457 0.0410
188 REBOUND ACID HYPERSECRETION 124 0.0410
189 PREGNANCY 820 0.0409
190 PARANASAL SINUS DISCOMFORT 153 0.0404
191 PRODUCT USE ISSUE 7584 0.0403
192 PARAESTHESIA ORAL 572 0.0396
193 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 674 0.0393
194 INFECTION 5650 0.0390
195 MUSCULOSKELETAL PAIN 2036 0.0388
196 MUSCLE SPASTICITY 474 0.0385
197 MIGRAINE 3674 0.0384
198 ANGIOEDEMA 1687 0.0381
199 DELIRIUM 1321 0.0380
200 SCRATCH 395 0.0374
201 POST-TRAUMATIC STRESS DISORDER 250 0.0373
202 SNORING 141 0.0373
203 LIVER DISORDER 1646 0.0371
204 ADRENAL INSUFFICIENCY 450 0.0370
205 JOINT STIFFNESS 966 0.0368
206 INFUSION SITE PAIN 474 0.0367
207 INFUSION SITE ERYTHEMA 309 0.0366
208 MONOCYTE COUNT INCREASED 133 0.0366
209 LIP SWELLING 1213 0.0364
210 UPPER-AIRWAY COUGH SYNDROME 299 0.0363
211 RESPIRATORY DISORDER 1079 0.0360
212 NASOPHARYNGITIS 6631 0.0359
213 HEREDITARY ANGIOEDEMA 384 0.0357
214 DRUG-INDUCED LIVER INJURY 1119 0.0356
215 EYE PRURITUS 1187 0.0353
216 THERAPY NON-RESPONDER 1563 0.0347
217 APLASTIC ANAEMIA 180 0.0344
218 DEMYELINATION 141 0.0344
219 ADVERSE REACTION 452 0.0341
220 SINUS DISORDER 675 0.0340
221 RHINITIS 274 0.0339
222 CONFUSIONAL STATE 5485 0.0339
223 PRURITUS 12979 0.0337
224 PULMONARY FUNCTION TEST DECREASED 147 0.0335
225 CYSTIC FIBROSIS 185 0.0334
226 PHARYNGEAL SWELLING 319 0.0326
227 MYOSITIS 291 0.0324
228 AMNESIA 2107 0.0324
229 MUSCLE TWITCHING 745 0.0323
230 DYSPEPSIA 3151 0.0320
231 BODY TEMPERATURE INCREASED 653 0.0320
232 HYPOAESTHESIA 4778 0.0319
233 RHINOVIRUS INFECTION 124 0.0318
234 SINUS CONGESTION 429 0.0317
235 TEMPERATURE INTOLERANCE 326 0.0316
236 RASH 13756 0.0315
237 GASTROOESOPHAGEAL REFLUX DISEASE 2515 0.0312
238 VITAMIN B12 DEFICIENCY 126 0.0311
239 MIDDLE INSOMNIA 579 0.0310
240 THROAT CLEARING 116 0.0309
241 DISABILITY 606 0.0306
242 CHOLECYSTITIS CHRONIC 205 0.0306
243 WEIGHT INCREASED 6746 0.0301
244 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2132 0.0299
245 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1426 0.0297
246 PRODUCT ADMINISTRATION INTERRUPTED 233 0.0297
247 GASTROENTERITIS VIRAL 535 0.0296
248 HYPERTENSION 6239 0.0294
249 WEIGHT FLUCTUATION 308 0.0294
250 SKIN WEEPING 105 0.0294
251 NASAL DRYNESS 184 0.0293
252 SINUS HEADACHE 174 0.0293
253 VENTRICULAR TACHYCARDIA 483 0.0292
254 VITAMIN D DEFICIENCY 285 0.0292
255 PERIORBITAL SWELLING 165 0.0292
256 WITHDRAWAL SYNDROME 1225 0.0291
257 OSTEOPOROSIS 1198 0.0291
258 SLEEP APNOEA SYNDROME 555 0.0291
259 GENERAL SYMPTOM 217 0.0289
260 PRODUCT USE IN UNAPPROVED INDICATION 7110 0.0287
261 BLOOD PRESSURE DIASTOLIC INCREASED 132 0.0286
262 DERMATITIS CONTACT 322 0.0282
263 ANAPHYLACTIC REACTION 1558 0.0282
264 SNEEZING 631 0.0281
265 ORAL CANDIDIASIS 370 0.0281
266 SKIN PLAQUE 237 0.0281
267 SENSITIVITY TO WEATHER CHANGE 147 0.0279
268 NASAL CONGESTION 1592 0.0271
269 ABDOMINAL PAIN UPPER 5573 0.0270
270 MOUTH SWELLING 154 0.0267
271 PRURITUS GENERALISED 574 0.0265
272 NECK PAIN 1481 0.0265
273 PAIN 16194 0.0263
274 IMPAIRED QUALITY OF LIFE 379 0.0263
275 SOMNAMBULISM 173 0.0263
276 EXPIRED PRODUCT ADMINISTERED 874 0.0263
277 MUSCULAR WEAKNESS 2980 0.0262
278 HEPATITIS 665 0.0260
279 URINE ABNORMALITY 118 0.0259
280 VAGINAL DISCHARGE 262 0.0259
281 ATTENTION DEFICIT HYPERACTIVITY DISORDER 109 0.0259
282 PHARYNGITIS STREPTOCOCCAL 280 0.0258
283 INFUSION SITE EXTRAVASATION 161 0.0258
284 FREQUENT BOWEL MOVEMENTS 697 0.0258
285 WRONG DRUG ADMINISTERED 229 0.0257
286 ARTHRALGIA 10664 0.0256
287 PRODUCT LABEL ISSUE 172 0.0253
288 RASH ERYTHEMATOUS 1208 0.0252
289 BACK DISORDER 407 0.0250
290 CONDITION AGGRAVATED 7585 0.0249
291 SOMNOLENCE 5019 0.0249
292 ARTHROPOD BITE 184 0.0248
293 BRONCHITIS 1834 0.0248
294 PAIN OF SKIN 666 0.0247
295 FATIGUE 19252 0.0247
296 SWELLING OF EYELID 155 0.0247
297 SKIN ABRASION 116 0.0245
298 THROAT IRRITATION 1098 0.0244
299 MEMORY IMPAIRMENT 3351 0.0244
300 DIPLOPIA 633 0.0243
301 RASH PAPULAR 546 0.0243
302 BREATH SOUNDS ABNORMAL 120 0.0243
303 PYREXIA 8400 0.0243
304 SPUTUM DISCOLOURED 230 0.0242
305 SYMPTOM RECURRENCE 145 0.0242
306 DERMATITIS ATOPIC 1276 0.0242
307 SUSPECTED OFF LABEL USE 109 0.0241
308 FLUID RETENTION 1226 0.0241
309 ECZEMA 1251 0.0239
310 INSOMNIA 6314 0.0237
311 SKIN WARM 136 0.0234
312 ACCIDENTAL OVERDOSE 855 0.0233
313 THROAT TIGHTNESS 629 0.0232
314 SYNOVIAL CYST 107 0.0232
315 PRODUCTIVE COUGH 1106 0.0231
316 FOOT OPERATION 113 0.0228
317 EOSINOPHIL COUNT INCREASED 190 0.0228
318 RHINORRHOEA 1466 0.0227
319 TIC 123 0.0225
320 PARAESTHESIA 3519 0.0223
321 CHEST PAIN 4122 0.0222
322 TENDERNESS 231 0.0221
323 SWOLLEN TONGUE 692 0.0221
324 STREPTOCOCCAL INFECTION 123 0.0221
325 DISTURBANCE IN ATTENTION 1189 0.0220
326 FOOD POISONING 118 0.0220
327 ENDOMETRIOSIS 105 0.0220
328 ADVERSE EVENT 2028 0.0220
329 BLOOD PRESSURE DIASTOLIC DECREASED 162 0.0219
330 BRAIN FOG 342 0.0218
331 OROPHARYNGEAL DISCOMFORT 197 0.0218
332 ARTHRITIS 1715 0.0218
333 PRODUCT PACKAGING ISSUE 207 0.0218
334 NASAL POLYPS 107 0.0217
335 PAPULE 153 0.0217
336 FLANK PAIN 203 0.0216
337 ADVERSE DRUG REACTION 1937 0.0215
338 BLOOD PRESSURE SYSTOLIC INCREASED 420 0.0215
339 SKIN HAEMORRHAGE 319 0.0215
340 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 146 0.0215
341 CHOLECYSTITIS ACUTE 121 0.0213
342 INTERVERTEBRAL DISC DEGENERATION 197 0.0213
343 BRONCHIECTASIS 143 0.0212
344 TRANSIENT ISCHAEMIC ATTACK 711 0.0211
345 MEDICATION ERROR 1166 0.0210
346 FEELING HOT 1286 0.0210
347 SPINAL OSTEOARTHRITIS 184 0.0209
348 COORDINATION ABNORMAL 292 0.0209
349 DEPRESSION 4743 0.0208
350 RESPIRATORY TRACT CONGESTION 331 0.0208
351 SWELLING FACE 1348 0.0207
352 HEADACHE 12972 0.0207
353 CONJUNCTIVITIS 381 0.0205
354 COGNITIVE DISORDER 958 0.0205
355 EYE SWELLING 763 0.0205
356 BRUXISM 110 0.0204
357 MUSCLE SPASMS 3743 0.0204
358 RESPIRATORY TRACT INFECTION 531 0.0204
359 TOOTH FRACTURE 224 0.0203
360 SECRETION DISCHARGE 254 0.0203
361 DYSPNOEA 11448 0.0202
362 MATERNAL EXPOSURE BEFORE PREGNANCY 138 0.0202
363 TINNITUS 928 0.0202
364 PHARYNGITIS 249 0.0201
365 ANXIETY 5679 0.0199
366 OROPHARYNGEAL PAIN 1844 0.0199
367 FEELING DRUNK 148 0.0199
368 RASH PRURITIC 1073 0.0198
369 CHEST DISCOMFORT 2027 0.0198
370 CONCUSSION 153 0.0197
371 DRUG USE DISORDER 166 0.0197
372 LACRIMATION INCREASED 595 0.0197
373 DRY EYE 980 0.0196
374 RETCHING 417 0.0195
375 TACHYCARDIA 1730 0.0195
376 HEART RATE INCREASED 1919 0.0194
377 OEDEMA PERIPHERAL 2359 0.0193
378 SKIN INFECTION 217 0.0193
379 INITIAL INSOMNIA 198 0.0193
380 VIRAL INFECTION 642 0.0193
381 THERAPEUTIC RESPONSE DECREASED 1166 0.0192
382 SKIN FISSURES 375 0.0192
383 HYPERHIDROSIS 2445 0.0190
384 INSURANCE ISSUE 290 0.0189
385 NODULE 246 0.0188
386 INJECTION SITE REACTION 1294 0.0188
387 INTENTIONAL PRODUCT MISUSE 1635 0.0187
388 TENDON DISORDER 121 0.0185
389 RECTAL HAEMORRHAGE 796 0.0185
390 DECREASED APPETITE 4283 0.0184
391 ULCER 293 0.0184
392 MENISCUS INJURY 113 0.0184
393 PROCTALGIA 118 0.0183
394 FULL BLOOD COUNT ABNORMAL 194 0.0183
395 COUGH 5135 0.0183
396 HIATUS HERNIA 237 0.0183
397 NASAL DISCOMFORT 145 0.0183
398 RALES 106 0.0182
399 APPETITE DISORDER 121 0.0182
400 ROTATOR CUFF SYNDROME 234 0.0182
401 VOMITING 8560 0.0182
402 DRY THROAT 185 0.0182
403 PSYCHOMOTOR HYPERACTIVITY 302 0.0182
404 BREAST MASS 122 0.0181
405 CHRONIC KIDNEY DISEASE 1380 0.0181
406 RESPIRATORY SYNCYTIAL VIRUS INFECTION 158 0.0181
407 EAR DISCOMFORT 186 0.0181
408 JOINT INJURY 387 0.0181
409 SPINAL DISORDER 171 0.0180
410 RESTLESS LEGS SYNDROME 327 0.0180
411 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 985 0.0179
412 APHONIA 250 0.0179
413 WHITE BLOOD CELL COUNT INCREASED 685 0.0178
414 RASH MACULAR 622 0.0178
415 TOOTH ABSCESS 181 0.0178
416 SLUGGISHNESS 181 0.0177
417 POOR QUALITY SLEEP 382 0.0177
418 END STAGE RENAL DISEASE 323 0.0177
419 ATELECTASIS 171 0.0177
420 SKIN LESION 484 0.0176
421 COVID-19 3090 0.0176
422 OSTEOPENIA 267 0.0176
423 DIZZINESS 8770 0.0176
424 EOSINOPHILIA 307 0.0175
425 SENSATION OF FOREIGN BODY 147 0.0174
426 IMPAIRED GASTRIC EMPTYING 237 0.0174
427 PALPITATIONS 2036 0.0174
428 OBSESSIVE-COMPULSIVE DISORDER 139 0.0173
429 MYDRIASIS 222 0.0173
430 INTERVERTEBRAL DISC PROTRUSION 378 0.0173
431 PHOTOPHOBIA 325 0.0173
432 CARPAL TUNNEL SYNDROME 242 0.0173
433 MALAISE 7574 0.0173
434 BODY TEMPERATURE DECREASED 170 0.0173
435 JOINT EFFUSION 119 0.0172
436 PHARYNGEAL OEDEMA 265 0.0172
437 PNEUMONIA 5577 0.0172
438 PROCEDURAL PAIN 477 0.0172
439 BLOOD MAGNESIUM DECREASED 148 0.0171
440 ABDOMINAL PAIN 3986 0.0171
441 PHOTOSENSITIVITY REACTION 280 0.0169
442 LIGAMENT SPRAIN 167 0.0169
443 WRONG PRODUCT ADMINISTERED 114 0.0169
444 PAIN IN EXTREMITY 4968 0.0168
445 ERYTHEMA 3463 0.0168
446 SCAB 192 0.0168
447 VISUAL IMPAIRMENT 2085 0.0168
448 HYPERSOMNIA 482 0.0168
449 COLITIS ULCERATIVE 751 0.0168
450 DYSPHONIA 982 0.0168
451 DRUG INEFFECTIVE 22109 0.0168
452 VITAMIN D DECREASED 143 0.0167
453 OFF LABEL USE 14620 0.0167
454 AFFECTIVE DISORDER 131 0.0166
455 BACK PAIN 3864 0.0166
456 ABDOMINAL DISTENSION 1736 0.0166
457 CYTOKINE RELEASE SYNDROME 332 0.0165
458 DYSPNOEA EXERTIONAL 623 0.0165
459 FORMICATION 115 0.0165
460 FEELING JITTERY 314 0.0165
461 SKIN REACTION 232 0.0165
462 DIVERTICULUM 117 0.0164
463 THERAPEUTIC RESPONSE SHORTENED 545 0.0164
464 HYPOAESTHESIA ORAL 247 0.0164
465 DRY SKIN 2172 0.0163
466 ORAL HERPES 316 0.0162
467 BLOOD IRON DECREASED 192 0.0162
468 ILLNESS 1662 0.0161
469 GAIT DISTURBANCE 3086 0.0161
470 DERMATITIS ALLERGIC 202 0.0160
471 BRONCHOSPASM 229 0.0160
472 PAROSMIA 121 0.0160
473 IRON DEFICIENCY ANAEMIA 148 0.0160
474 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 132 0.0160
475 HYPERLIPIDAEMIA 191 0.0160
476 PRODUCT QUALITY ISSUE 2159 0.0159
477 SENSITIVE SKIN 117 0.0158
478 DIARRHOEA 10209 0.0158
479 RESPIRATION ABNORMAL 109 0.0158
480 SKIN SWELLING 137 0.0158
481 OXYGEN SATURATION DECREASED 886 0.0157
482 POOR VENOUS ACCESS 163 0.0157
483 MAJOR DEPRESSION 115 0.0157
484 WEIGHT DECREASED 4366 0.0156
485 PRODUCT DISTRIBUTION ISSUE 145 0.0156
486 PRODUCT DOSE OMISSION IN ERROR 442 0.0156
487 GINGIVAL PAIN 124 0.0156
488 INCREASED TENDENCY TO BRUISE 143 0.0155
489 LYMPHOCYTE COUNT DECREASED 274 0.0155
490 ORAL PAIN 347 0.0155
491 FRUSTRATION TOLERANCE DECREASED 125 0.0155
492 ASTHENIA 5808 0.0154
493 DEPRESSED MOOD 815 0.0154
494 LIMB DISCOMFORT 477 0.0154
495 ORAL DISORDER 113 0.0154
496 NAUSEA 12171 0.0154
497 CRYING 557 0.0153
498 HALLUCINATION 1150 0.0152
499 GALLBLADDER DISORDER 272 0.0152
500 BLOOD PRESSURE FLUCTUATION 365 0.0152
501 DECREASED ACTIVITY 164 0.0152
502 NIGHTMARE 522 0.0151
503 HEAD DISCOMFORT 267 0.0151
504 LABORATORY TEST ABNORMAL 445 0.0151
505 HYPOKALAEMIA 694 0.0150
506 CARDIAC MURMUR 130 0.0150
507 SKIN LACERATION 163 0.0150
508 HYPERTRANSAMINASAEMIA 104 0.0149
509 PSYCHOLOGICAL TRAUMA 129 0.0149
510 NEUTROPHIL COUNT INCREASED 153 0.0149
511 INFLUENZA 1652 0.0148
512 BLINDNESS 602 0.0148
513 THINKING ABNORMAL 275 0.0147
514 RESPIRATORY RATE INCREASED 131 0.0147
515 TRICUSPID VALVE INCOMPETENCE 117 0.0147
516 ANGER 496 0.0147
517 EYE DISCHARGE 152 0.0146
518 FEELING ABNORMAL 3505 0.0146
519 EYE INFECTION 165 0.0146
520 BLOOD PRESSURE INCREASED 2230 0.0146
521 BLOOD POTASSIUM DECREASED 437 0.0145
522 MUSCULOSKELETAL DISCOMFORT 250 0.0145
523 EXTRA DOSE ADMINISTERED 588 0.0145
524 TONGUE DISORDER 105 0.0145
525 DECREASED IMMUNE RESPONSIVENESS 142 0.0145
526 CANDIDA INFECTION 244 0.0144
527 BODY HEIGHT DECREASED 154 0.0144
528 ECONOMIC PROBLEM 218 0.0144
529 PANIC ATTACK 524 0.0144
530 PETECHIAE 150 0.0144
531 OCULAR HYPERAEMIA 682 0.0144
532 GASTROENTERITIS 209 0.0143
533 BLOOD CALCIUM DECREASED 161 0.0143
534 FUNGAL INFECTION 477 0.0143
535 PULMONARY CONGESTION 188 0.0142
536 FOOT FRACTURE 270 0.0142
537 PULMONARY MASS 212 0.0142
538 CARDIOMEGALY 175 0.0142
539 MITRAL VALVE INCOMPETENCE 161 0.0142
540 CONSTIPATION 3087 0.0141
541 DERMATITIS 296 0.0141
542 TOOTH INFECTION 186 0.0141
543 HAIR DISORDER 116 0.0141
544 PRESYNCOPE 341 0.0140
545 SCAR 240 0.0140
546 SARS-COV-2 TEST POSITIVE 185 0.0140
547 MUSCLE STRAIN 121 0.0140
548 PSORIASIS 1824 0.0140
549 LIMB INJURY 378 0.0139
550 NERVE COMPRESSION 128 0.0139
551 HAIR COLOUR CHANGES 172 0.0138
552 DIZZINESS POSTURAL 134 0.0138
553 VERTIGO 841 0.0138
554 QUALITY OF LIFE DECREASED 185 0.0138
555 FLUSHING 1396 0.0137
556 MUSCLE TIGHTNESS 222 0.0137
557 LYMPHADENOPATHY 484 0.0137
558 INJECTION SITE URTICARIA 334 0.0136
559 DYSPHAGIA 1291 0.0136
560 RENAL CYST 108 0.0136
561 ANHEDONIA 357 0.0136
562 BLOOD TEST ABNORMAL 190 0.0135
563 GASTRITIS 355 0.0135
564 CHOLECYSTECTOMY 154 0.0135
565 GASTROINTESTINAL PAIN 148 0.0134
566 PRODUCT TASTE ABNORMAL 182 0.0134
567 DRUG EFFECT INCOMPLETE 488 0.0134
568 ASPIRATION 147 0.0134
569 DYSURIA 494 0.0134
570 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 104 0.0134
571 BLOOD UREA INCREASED 224 0.0134
572 DEHYDRATION 1784 0.0134
573 MUSCULOSKELETAL CHEST PAIN 207 0.0134
574 UNDERDOSE 976 0.0134
575 MOOD ALTERED 363 0.0133
576 MASS 185 0.0132
577 DRUG EFFECT LESS THAN EXPECTED 196 0.0132
578 URINARY TRACT INFECTION 2251 0.0132
579 GINGIVAL BLEEDING 180 0.0132
580 SKIN EXFOLIATION 1111 0.0132
581 PRODUCT ADMINISTRATION ERROR 266 0.0131
582 INCORRECT PRODUCT ADMINISTRATION DURATION 284 0.0131
583 OCULAR DISCOMFORT 147 0.0131
584 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 683 0.0131
585 EMPHYSEMA 132 0.0131
586 COLITIS 496 0.0131
587 NEPHROLITHIASIS 599 0.0130
588 ANKLE FRACTURE 202 0.0130
589 AGEUSIA 325 0.0130
590 DENTAL CARIES 144 0.0130
591 CHILLS 1524 0.0130
592 TENDONITIS 201 0.0130
593 EYE IRRITATION 747 0.0130
594 DISEASE RECURRENCE 617 0.0130
595 HYSTERECTOMY 112 0.0129
596 HAEMORRHOIDS 252 0.0129
597 INTENTIONAL DOSE OMISSION 368 0.0129
598 RASH MACULO-PAPULAR 287 0.0129
599 VENTRICULAR EXTRASYSTOLES 133 0.0128
600 OVARIAN CYST 128 0.0128
601 HAEMATOCRIT DECREASED 253 0.0127
602 OVERDOSE 2751 0.0127
603 SUPRAVENTRICULAR TACHYCARDIA 122 0.0127
604 GASTROINTESTINAL INFECTION 114 0.0127
605 PSEUDOMONAS INFECTION 109 0.0127
606 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2290 0.0127
607 IRRITABILITY 763 0.0127
608 CHOLELITHIASIS 416 0.0127
609 CHOLECYSTITIS 151 0.0127
610 AGGRESSION 634 0.0127
611 THIRST 226 0.0126
612 COVID-19 PNEUMONIA 149 0.0126
613 HEAD INJURY 397 0.0125
614 EYE PAIN 706 0.0125
615 HEPATIC STEATOSIS 233 0.0125
616 BALANCE DISORDER 1080 0.0125
617 RED BLOOD CELL COUNT DECREASED 357 0.0125
618 HEART RATE IRREGULAR 282 0.0125
619 CYSTITIS 397 0.0125
620 UROSEPSIS 115 0.0125
621 LETHARGY 717 0.0125
622 SENSORY DISTURBANCE 200 0.0124
623 EPISTAXIS 932 0.0124
624 HYPOMAGNESAEMIA 173 0.0124
625 BURNING SENSATION 870 0.0124
626 MOOD SWINGS 395 0.0124
627 PAIN IN JAW 351 0.0124
628 NEURALGIA 301 0.0124
629 DIVERTICULITIS 343 0.0124
630 NOCTURIA 150 0.0123
631 ANAPHYLACTIC SHOCK 318 0.0123
632 CLOSTRIDIUM DIFFICILE INFECTION 269 0.0123
633 MOUTH ULCERATION 259 0.0123
634 DYSGEUSIA 913 0.0123
635 FACE OEDEMA 207 0.0123
636 HAIR TEXTURE ABNORMAL 164 0.0122
637 EYE DISORDER 403 0.0122
638 MICTURITION URGENCY 140 0.0122
639 URINARY INCONTINENCE 363 0.0122
640 FEELING COLD 341 0.0122
641 CELLULITIS 617 0.0122
642 KIDNEY INFECTION 239 0.0122
643 ACUTE RESPIRATORY FAILURE 234 0.0122
644 PLATELET COUNT INCREASED 158 0.0121
645 CHOKING 236 0.0121
646 HOT FLUSH 909 0.0120
647 HEART RATE DECREASED 423 0.0120
648 BLOOD SODIUM DECREASED 227 0.0120
649 SINUS TACHYCARDIA 171 0.0120
650 INJECTION SITE RASH 368 0.0120
651 PURPURA 106 0.0120
652 RASH GENERALISED 310 0.0120
653 PRODUCT DOSE OMISSION ISSUE 3511 0.0119
654 BLOOD COUNT ABNORMAL 181 0.0119
655 PANCREATITIS 630 0.0119
656 SKIN DISORDER 397 0.0119
657 IMPAIRED WORK ABILITY 252 0.0118
658 FALL 3903 0.0117
659 BLOOD URINE PRESENT 222 0.0117
660 PARANOIA 201 0.0116
661 INCREASED APPETITE 222 0.0116
662 DYSARTHRIA 437 0.0116
663 WRIST FRACTURE 138 0.0115
664 HERPES ZOSTER 660 0.0115
665 ABNORMAL DREAMS 317 0.0115
666 ERYTHEMA MULTIFORME 107 0.0115
667 HYPOXIA 404 0.0115
668 SKIN DISCOLOURATION 527 0.0115
669 PRODUCT PHYSICAL ISSUE 230 0.0114
670 STAPHYLOCOCCAL INFECTION 376 0.0114
671 RIB FRACTURE 234 0.0114
672 FLATULENCE 645 0.0114
673 ACCIDENT 135 0.0113
674 FEAR 304 0.0113
675 ABNORMAL BEHAVIOUR 445 0.0112
676 INJECTION SITE SWELLING 860 0.0112
677 PERIPHERAL COLDNESS 154 0.0112
678 CHROMATURIA 253 0.0112
679 MADAROSIS 130 0.0112
680 HUNGER 156 0.0112
681 BLOOD ALKALINE PHOSPHATASE INCREASED 278 0.0112
682 MYALGIA 1902 0.0112
683 DRUG ADMINISTRATION ERROR 342 0.0111
684 SUICIDAL IDEATION 1017 0.0111
685 TOOTHACHE 201 0.0111
686 POLLAKIURIA 463 0.0111
687 GOUT 199 0.0111
688 URINARY RETENTION 370 0.0111
689 ORAL DISCOMFORT 154 0.0111
690 INJECTION SITE PRURITUS 742 0.0111
691 DISORIENTATION 438 0.0110
692 BIPOLAR DISORDER 120 0.0110
693 IMMUNE SYSTEM DISORDER 145 0.0110
694 HYPOCALCAEMIA 208 0.0110
695 THERAPY PARTIAL RESPONDER 171 0.0110
696 TREMOR 1819 0.0109
697 NEUROPATHY PERIPHERAL 1041 0.0109
698 TOOTH DISORDER 243 0.0109
699 BLOOD PRESSURE DECREASED 724 0.0109
700 NERVOUSNESS 569 0.0109
701 SINUS BRADYCARDIA 105 0.0109
702 UPPER LIMB FRACTURE 216 0.0108
703 EYE INFLAMMATION 103 0.0108
704 ASPARTATE AMINOTRANSFERASE INCREASED 572 0.0108
705 HAEMATOCHEZIA 594 0.0108
706 SYNCOPE 1075 0.0107
707 RESTLESSNESS 393 0.0107
708 MUCOSAL INFLAMMATION 281 0.0107
709 SMALL INTESTINAL OBSTRUCTION 132 0.0107
710 ALANINE AMINOTRANSFERASE INCREASED 658 0.0107
711 REBOUND EFFECT 121 0.0107
712 HAEMOPTYSIS 298 0.0107
713 KNEE OPERATION 105 0.0107
714 THYROID DISORDER 164 0.0106
715 SEIZURE 1225 0.0106
716 FEEDING DISORDER 215 0.0106
717 IMPAIRED DRIVING ABILITY 120 0.0105
718 CYST 131 0.0105
719 CATARACT 628 0.0105
720 NERVE INJURY 117 0.0105
721 GLOMERULAR FILTRATION RATE DECREASED 129 0.0105
722 TOXIC EPIDERMAL NECROLYSIS 159 0.0105
723 LOSS OF CONSCIOUSNESS 1341 0.0105
724 PULMONARY HYPERTENSION 218 0.0105
725 BONE PAIN 613 0.0105
726 EYELID OEDEMA 121 0.0104
727 BASAL CELL CARCINOMA 162 0.0104
728 SEDATION 271 0.0103
729 VISION BLURRED 1409 0.0103
730 BONE DISORDER 187 0.0103
731 FEBRILE NEUTROPENIA 679 0.0102
732 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 263 0.0102
733 PULMONARY ARTERIAL HYPERTENSION 147 0.0101
734 AGITATION 745 0.0101
735 ACUTE KIDNEY INJURY 1546 0.0101
736 COLD SWEAT 178 0.0101
737 STEVENS-JOHNSON SYNDROME 224 0.0101
738 THROMBOCYTOPENIA 1126 0.0101
739 HEPATOCELLULAR INJURY 142 0.0100
740 JAUNDICE 269 0.0100
741 BLOOD TRIGLYCERIDES INCREASED 176 0.0100
742 INFLUENZA LIKE ILLNESS 817 0.0099
743 TRANSFUSION 104 0.0099
744 TUBULOINTERSTITIAL NEPHRITIS 186 0.0099
745 EATING DISORDER 211 0.0099
746 APHASIA 299 0.0099
747 GLAUCOMA 190 0.0099
748 INJECTION SITE DISCOLOURATION 123 0.0098
749 EMOTIONAL DISORDER 303 0.0098
750 SPINAL OPERATION 121 0.0098
751 BACTERIAL INFECTION 183 0.0098
752 DYSSTASIA 286 0.0098
753 POST PROCEDURAL COMPLICATION 188 0.0098
754 HYPOTHYROIDISM 312 0.0098
755 INJECTION SITE ERYTHEMA 1209 0.0097
756 LOCALISED INFECTION 235 0.0097
757 PRODUCT USE COMPLAINT 153 0.0097
758 DEEP VEIN THROMBOSIS 631 0.0097
759 INJECTION SITE WARMTH 199 0.0097
760 MANIA 159 0.0097
761 DRUG ERUPTION 171 0.0096
762 HYPOTENSION 1931 0.0096
763 PRODUCT AVAILABILITY ISSUE 219 0.0096
764 GENERALISED OEDEMA 119 0.0096
765 OESOPHAGITIS 105 0.0096
766 PLEURAL EFFUSION 583 0.0096
767 ORTHOSTATIC HYPOTENSION 166 0.0095
768 FULL BLOOD COUNT DECREASED 190 0.0094
769 HALLUCINATION, VISUAL 199 0.0094
770 POISONING 118 0.0094
771 INCORRECT DOSE ADMINISTERED 2142 0.0094
772 SPEECH DISORDER 490 0.0093
773 SPLENOMEGALY 109 0.0093
774 DYSMENORRHOEA 123 0.0093
775 RENAL FAILURE 1230 0.0093
776 BLOOD PRESSURE ABNORMAL 184 0.0092
777 PELVIC PAIN 168 0.0092
778 THERAPY CESSATION 474 0.0092
779 FOETAL EXPOSURE DURING PREGNANCY 748 0.0092
780 HYPOKINESIA 133 0.0092
781 TOOTH EXTRACTION 114 0.0092
782 SURGERY 537 0.0092
783 DEVICE RELATED INFECTION 140 0.0091
784 PULMONARY EMBOLISM 859 0.0090
785 MOVEMENT DISORDER 290 0.0090
786 CYANOSIS 142 0.0090
787 SKIN ULCER 230 0.0089
788 PNEUMONITIS 242 0.0089
789 RENAL INJURY 264 0.0089
790 LOCAL SWELLING 155 0.0089
791 COMPLICATION ASSOCIATED WITH DEVICE 129 0.0089
792 PARALYSIS 127 0.0089
793 FAECES DISCOLOURED 192 0.0088
794 INJECTION SITE BRUISING 706 0.0088
795 RESPIRATORY DISTRESS 244 0.0088
796 PRODUCT SUBSTITUTION ISSUE 508 0.0088
797 SKIN IRRITATION 403 0.0088
798 INJECTION SITE INDURATION 114 0.0088
799 PHARMACEUTICAL PRODUCT COMPLAINT 228 0.0088
800 DIABETES MELLITUS 666 0.0087
801 PALLOR 237 0.0087
802 UNEVALUABLE EVENT 654 0.0086
803 PANCREATITIS ACUTE 194 0.0086
804 BLOOD POTASSIUM INCREASED 140 0.0086
805 ATRIAL FIBRILLATION 838 0.0086
806 ACTIVITIES OF DAILY LIVING IMPAIRED 170 0.0086
807 HYPONATRAEMIA 483 0.0086
808 HERNIA 165 0.0085
809 ELECTROCARDIOGRAM QT PROLONGED 306 0.0085
810 TENDON RUPTURE 105 0.0085
811 CORONARY ARTERY DISEASE 257 0.0085
812 ERUCTATION 164 0.0085
813 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1713 0.0084
814 MENTAL DISORDER 365 0.0084
815 MULTIPLE SCLEROSIS 400 0.0084
816 EXPOSURE VIA SKIN CONTACT 216 0.0083
817 TACHYPNOEA 113 0.0083
818 DRUG INTERACTION 1314 0.0083
819 GENERALISED TONIC-CLONIC SEIZURE 137 0.0083
820 GASTRIC DISORDER 284 0.0083
821 HYPOPHAGIA 210 0.0082
822 INJECTION SITE PAIN 2517 0.0082
823 SKIN BURNING SENSATION 587 0.0082
824 INTENTIONAL SELF-INJURY 165 0.0082
825 WHITE BLOOD CELL COUNT DECREASED 878 0.0081
826 INJECTION SITE IRRITATION 103 0.0081
827 ABSCESS 128 0.0080
828 INTESTINAL OBSTRUCTION 302 0.0080
829 SPINAL FRACTURE 159 0.0079
830 DYSKINESIA 321 0.0079
831 TREATMENT NONCOMPLIANCE 431 0.0079
832 NEEDLE ISSUE 229 0.0079
833 ANAEMIA 1498 0.0078
834 LYMPHOPENIA 111 0.0078
835 ACNE 595 0.0078
836 INJECTION SITE MASS 289 0.0078
837 ABORTION SPONTANEOUS 313 0.0078
838 GASTRIC ULCER 148 0.0078
839 DYSTONIA 151 0.0078
840 HOSPITALISATION 1195 0.0078
841 HAEMOGLOBIN DECREASED 798 0.0078
842 LEUKOCYTOSIS 140 0.0077
843 HEMIPARESIS 131 0.0077
844 THERAPY INTERRUPTED 552 0.0077
845 DRUG DISPENSING ERROR 118 0.0077
846 LEUKOPENIA 386 0.0077
847 BRADYCARDIA 409 0.0077
848 BLOOD CREATININE INCREASED 503 0.0077
849 DRUG PRESCRIBING ERROR 148 0.0077
850 DRUG EFFECT DECREASED 414 0.0077
851 OSTEOMYELITIS 139 0.0077
852 APATHY 111 0.0076
853 HYPERGLYCAEMIA 276 0.0076
854 DELUSION 117 0.0075
855 CORONARY ARTERY OCCLUSION 103 0.0075
856 PNEUMOTHORAX 119 0.0075
857 LIVER FUNCTION TEST ABNORMAL 218 0.0075
858 HAEMATOMA 194 0.0075
859 PERICARDIAL EFFUSION 173 0.0075
860 ABDOMINAL PAIN LOWER 187 0.0074
861 DRUG ABUSE 615 0.0074
862 EMOTIONAL DISTRESS 889 0.0073
863 SEPTIC SHOCK 319 0.0073
864 PLATELET COUNT DECREASED 778 0.0073
865 DEVICE FAILURE 111 0.0073
866 BLOOD GLUCOSE INCREASED 1367 0.0072
867 PULMONARY OEDEMA 324 0.0072
868 RENAL DISORDER 336 0.0072
869 THROMBOSIS 580 0.0072
870 MUSCULOSKELETAL DISORDER 137 0.0072
871 HYPERKALAEMIA 251 0.0072
872 PNEUMONIA ASPIRATION 178 0.0071
873 CARDIAC FAILURE CONGESTIVE 571 0.0071
874 EJECTION FRACTION DECREASED 110 0.0071
875 RESPIRATORY FAILURE 514 0.0070
876 DIABETES MELLITUS INADEQUATE CONTROL 124 0.0070
877 METRORRHAGIA 119 0.0070
878 MENTAL IMPAIRMENT 169 0.0070
879 MENORRHAGIA 136 0.0069
880 DEAFNESS 181 0.0069
881 MENTAL STATUS CHANGES 192 0.0069
882 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 491 0.0069
883 ANGINA PECTORIS 197 0.0069
884 VAGINAL HAEMORRHAGE 298 0.0069
885 HYPOGLYCAEMIA 333 0.0069
886 UNRESPONSIVE TO STIMULI 177 0.0069
887 PRODUCT DOSE OMISSION 447 0.0068
888 SEPSIS 759 0.0068
889 HALLUCINATION, AUDITORY 108 0.0068
890 CHOLESTASIS 130 0.0068
891 DEMENTIA 189 0.0068
892 GLYCOSYLATED HAEMOGLOBIN INCREASED 170 0.0067
893 SUICIDE ATTEMPT 408 0.0067
894 PRODUCT PRESCRIBING ERROR 160 0.0067
895 CONVULSION 384 0.0067
896 HYPOACUSIS 280 0.0065
897 ARRHYTHMIA 308 0.0065
898 HIP FRACTURE 209 0.0065
899 BLOOD BILIRUBIN INCREASED 174 0.0064
900 APPLICATION SITE PRURITUS 146 0.0064
901 ALTERED STATE OF CONSCIOUSNESS 139 0.0064
902 SKIN CANCER 138 0.0064
903 DRUG EXPOSURE DURING PREGNANCY 218 0.0064
904 CIRCULATORY COLLAPSE 109 0.0064
905 NO ADVERSE EVENT 1155 0.0064
906 GAMMA-GLUTAMYLTRANSFERASE INCREASED 141 0.0064
907 RENAL IMPAIRMENT 533 0.0063
908 ACUTE MYOCARDIAL INFARCTION 187 0.0063
909 COMA 301 0.0063
910 NEUTROPHIL COUNT DECREASED 257 0.0063
911 BLOOD GLUCOSE DECREASED 302 0.0063
912 PANCYTOPENIA 343 0.0061
913 CARDIAC DISORDER 569 0.0061
914 PSYCHOTIC DISORDER 177 0.0060
915 INJECTION SITE HAEMORRHAGE 478 0.0060
916 BONE DENSITY DECREASED 187 0.0060
917 HAEMATEMESIS 151 0.0060
918 MYOCARDIAL INFARCTION 1038 0.0059
919 ACCIDENTAL EXPOSURE TO PRODUCT 608 0.0059
920 MENSTRUATION IRREGULAR 157 0.0059
921 INTENTIONAL OVERDOSE 375 0.0058
922 PRODUCT PRESCRIBING ISSUE 127 0.0058
923 ENCEPHALOPATHY 143 0.0058
924 NERVOUS SYSTEM DISORDER 181 0.0058
925 HAEMATURIA 198 0.0058
926 APPLICATION SITE ERYTHEMA 151 0.0058
927 INCORRECT DRUG ADMINISTRATION DURATION 161 0.0057
928 GASTROINTESTINAL HAEMORRHAGE 478 0.0057
929 ERECTILE DYSFUNCTION 146 0.0057
930 MULTIPLE SCLEROSIS RELAPSE 387 0.0056
931 BLOOD GLUCOSE ABNORMAL 103 0.0056
932 HAEMORRHAGE 575 0.0055
933 DEVICE DELIVERY SYSTEM ISSUE 150 0.0055
934 DEVICE ISSUE 485 0.0054
935 DRUG WITHDRAWAL SYNDROME 473 0.0054
936 APPLICATION SITE PAIN 118 0.0054
937 TRANSAMINASES INCREASED 119 0.0053
938 CARDIAC ARREST 441 0.0053
939 DRUG DOSE OMISSION 880 0.0053
940 VISUAL ACUITY REDUCED 176 0.0053
941 FEMUR FRACTURE 164 0.0053
942 HEPATOTOXICITY 117 0.0052
943 PRODUCT DISPENSING ERROR 114 0.0052
944 DEVICE DISLOCATION 227 0.0052
945 DEVICE MALFUNCTION 364 0.0052
946 WRONG TECHNIQUE IN DRUG USAGE PROCESS 188 0.0052
947 PRODUCT PREPARATION ERROR 106 0.0052
948 INTERSTITIAL LUNG DISEASE 248 0.0051
949 CARDIAC FAILURE 410 0.0051
950 ABASIA 126 0.0051
951 MELAENA 112 0.0051
952 TARDIVE DYSKINESIA 143 0.0051
953 TOOTH LOSS 105 0.0051
954 NEUTROPENIA 670 0.0049
955 TOXICITY TO VARIOUS AGENTS 823 0.0049
956 OSTEONECROSIS OF JAW 119 0.0048
957 DIABETIC KETOACIDOSIS 115 0.0048
958 DEPRESSED LEVEL OF CONSCIOUSNESS 189 0.0048
959 HEPATIC FAILURE 144 0.0048
960 CEREBROVASCULAR ACCIDENT 809 0.0048
961 PLASMA CELL MYELOMA 184 0.0047
962 DEVICE BREAKAGE 191 0.0047
963 CARDIO-RESPIRATORY ARREST 195 0.0047
964 ASCITES 137 0.0047
965 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 135 0.0046
966 DISEASE PROGRESSION 536 0.0045
967 INTERNATIONAL NORMALISED RATIO INCREASED 127 0.0044
968 RHABDOMYOLYSIS 185 0.0044
969 RESPIRATORY ARREST 122 0.0044
970 OSTEONECROSIS 145 0.0044
971 BLOOD CREATINE PHOSPHOKINASE INCREASED 125 0.0043
972 PRODUCT COMPLAINT 109 0.0043
973 RENAL FAILURE ACUTE 181 0.0043
974 CEREBRAL HAEMORRHAGE 148 0.0041
975 NEOPLASM PROGRESSION 141 0.0041
976 COMPLETED SUICIDE 319 0.0038
977 DRUG DEPENDENCE 611 0.0038
978 LACTIC ACIDOSIS 121 0.0037
979 DEVICE USE ERROR 128 0.0037
980 MULTIPLE ORGAN DYSFUNCTION SYNDROME 103 0.0036
981 DEVICE LEAKAGE 157 0.0036
982 METABOLIC ACIDOSIS 115 0.0036
983 LUNG NEOPLASM MALIGNANT 145 0.0035
984 NEOPLASM MALIGNANT 232 0.0035
985 HEPATIC FUNCTION ABNORMAL 129 0.0035
986 MALIGNANT NEOPLASM PROGRESSION 308 0.0030
987 PRODUCT ADHESION ISSUE 105 0.0029
988 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 134 0.0029
989 DRUG DOSE OMISSION BY DEVICE 216 0.0028
990 DEATH 2347 0.0027
991 PRODUCT STORAGE ERROR 224 0.0026
992 BREAST CANCER 238 0.0026
993 DEVICE EXPULSION 156 0.0024